Dose-response effect of single and combined clofibrate (Atromidin®) and niceritrol (perycit®) treatment on serum lipids and lipoproteins in type II hyperlipoproteinaemia
- 31 August 1975
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 22 (1) , 91-101
- https://doi.org/10.1016/0021-9150(75)90070-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Clinical and metabolic effects of pentaerythritol tetranicotinate (perycit®) and a comparison with plain nicotinic acidAtherosclerosis, 1974
- Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIAJournal of Clinical Investigation, 1973
- Lipoprotein fractionation.Journal of Clinical Pathology, 1973
- Histochemical and functional effects of para-chlorophenoxyisobutyric acid on human liverPharmacological Research Communications, 1969
- Practical Methods for Plasma Lipoprotein Analysis1 1Work supported in part by the U.S. Atomic Energy Commission and by grants (HE06222 and FR00102) from the U.S. Public Health Service.Published by Elsevier ,1968
- Reduction of Cholesterol and Lipids in Man by Ethyl p-ChlorophenoxyisobutyrateAnnals of Internal Medicine, 1963
- Multicentre trial in the united kingdom and ireland of a mixture of ethyl chlorophenoxyisobutyrate and androsterone (atromid)Journal of Atherosclerosis Research, 1963
- The effects of atromid on serum lipids, proteins and some liver function tests in hypercholesterolaemic patientsJournal of Atherosclerosis Research, 1963
- The response of hyperlipoproteinemias to atromid and ethyl chlorophenoxyisobutyrateJournal of Atherosclerosis Research, 1963
- Hypercholesteremia and nicotinic acidThe American Journal of Medicine, 1961